Validation of the Decipher Genomic Classifier in Patients receiving Salvage Radiotherapy without Hormone Therapy after Radical Prostatectomy - An Ancillary Study of the SAKK 09/10 Randomized Clinical Trial.

Ann Oncol 2022 May 27

Validation of the Decipher Genomic Classifier in Patients receiving Salvage Radiotherapy without Hormone Therapy after Radical Prostatectomy - An Ancillary Study of the SAKK 09/10 Randomized Clinical Trial.

Related Questions

How would you manage an aortocaval nodal recurrence of prostate cancer in a patient who previously received salvage radiation to the fossa and pelvic nodes?

Assuming the recurrence is above the prior radiation field, would you cover the paraaortic region with an SIB or treat only the involved node? What do...

New comment by Radiation Oncologist at Stroger Hospital ( September 16, 2024)

Absolutely 45/25 with SIB boost

Read more (4 Answers available)

For a patient with a rising PSA after prostatectomy with seminal vesicles being negative for disease at surgery, do you ever treat the prostate bed and seminal vesicle bed with different doses in an SIB plan?

For example, the prostate bed/bladder neck receives 70 Gy and the seminal vesicle bed receives 60 Gy? Based on current randomized trials, what dose of...

New answer by Radiation Oncologist at National Institutes of Health Clinical Center (December 9, 2024)

Conclusion: The short answer is no, I do not utilize de-escalation to the SV bed, and I treat the entire operative bed to 64-66.6Gy. Below is a rationale and some linked ...

Read more (1 Answer available)